These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 12455724

  • 21. Assessment of plasma antioxidant status in hemodialysis patients.
    Kadkhodaee M, Hemmati M, Zahmatkesh M, Ghaznavi R, Mirershadi F, Mahdavi-Mazde M, Seifi B.
    Ther Apher Dial; 2008 Apr; 12(2):147-51. PubMed ID: 18387164
    [Abstract] [Full Text] [Related]

  • 22. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H, Wang SX.
    Blood Purif; 2008 Apr; 26(2):151-6. PubMed ID: 18212498
    [Abstract] [Full Text] [Related]

  • 23. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
    Hultqvist M, Hegbrant J, Nilsson-Thorell C, Lindholm T, Nilsson P, Lindén T, Hultqvist-Bengtsson U.
    Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
    [Abstract] [Full Text] [Related]

  • 24. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS.
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [Abstract] [Full Text] [Related]

  • 25. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C, Temiz A, Yeniçerioğlu Y, Calişkan S, Celik A, Sifil A, Onvural B, Camsari T.
    Scand J Urol Nephrol; 2003 Jan; 37(1):77-82. PubMed ID: 12745750
    [Abstract] [Full Text] [Related]

  • 26. Erythrocyte transmembrane electron transfer in haemodialysis patients.
    Matteucci E, Cupisti A, Caprioli R, Battipaglia E, Favilla S, Rindi P, Barsotti G, Giampietro O.
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
    [Abstract] [Full Text] [Related]

  • 27. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y, Nakayama M, Yoshimura K, Nakano H, Yamamoto H, Yokoyama K, Lindholm B.
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [Abstract] [Full Text] [Related]

  • 28. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
    Uzum A, Toprak O, Gumustas MK, Ciftci S, Sen S.
    J Nephrol; 2006 May; 19(6):739-45. PubMed ID: 17173246
    [Abstract] [Full Text] [Related]

  • 29. The effect of high-flux hemodialysis on renal anemia.
    Ayli D, Ayli M, Azak A, Yüksel C, Kosmaz GP, Atilgan G, Dede F, Abayli E, Camlibel M.
    J Nephrol; 2004 May; 17(5):701-6. PubMed ID: 15593038
    [Abstract] [Full Text] [Related]

  • 30. Subcutaneous epoetin-alpha every one, two, and three weeks in renal anemia.
    Piccoli A, Malagoli A, Komninos G, Pastori G.
    J Nephrol; 2002 May; 15(5):565-74. PubMed ID: 12455725
    [Abstract] [Full Text] [Related]

  • 31. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H, Mimura T, Honda N.
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [Abstract] [Full Text] [Related]

  • 32. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.
    J Nephrol; 2003 Oct; 16(4):522-34. PubMed ID: 14696754
    [Abstract] [Full Text] [Related]

  • 33. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia.
    Pfeifer WP, Degasperi GR, Almeida MT, Vercesi AE, Costa FF, Saad ST.
    Acta Haematol; 2008 Oct; 120(4):225-31. PubMed ID: 19218790
    [Abstract] [Full Text] [Related]

  • 34. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation.
    Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W.
    Wien Klin Wochenschr; 1997 Jan 17; 109(1):13-9. PubMed ID: 9037743
    [Abstract] [Full Text] [Related]

  • 35. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
    Morena M, Gausson V, Mothu N, Bouchet JL, Chanas M, Grandvuillemin M, Robert A, Vela C, Canaud B, Cristol JP, Olmer M.
    Blood Purif; 2008 Jan 17; 26(3):300-10. PubMed ID: 18451643
    [Abstract] [Full Text] [Related]

  • 36. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E, Vereckei A, Almási A, Rapavi E, Tasnádi G, Várnai K, Pallai Z, Lugasi A, Blázovics A.
    Clin Hemorheol Microcirc; 2007 Jan 17; 36(1):13-23. PubMed ID: 17211058
    [Abstract] [Full Text] [Related]

  • 37. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
    Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT.
    Kidney Int; 2006 Feb 17; 69(4):706-14. PubMed ID: 16395251
    [Abstract] [Full Text] [Related]

  • 38. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC, BA 16528 Study Investigators.
    Clin Nephrol; 2007 May 17; 67(5):306-17. PubMed ID: 17542340
    [Abstract] [Full Text] [Related]

  • 39. Vitamin E-coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients.
    Bargnoux AS, Cristol JP, Jaussent I, Chalabi L, Bories P, Dion JJ, Henri P, Delage M, Dupuy AM, Badiou S, Canaud B, Morena M.
    J Nephrol; 2013 May 17; 26(3):556-63. PubMed ID: 22956433
    [Abstract] [Full Text] [Related]

  • 40. Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients.
    Müller C, Eisenbrand G, Gradinger M, Rath T, Albert FW, Vienken J, Singh R, Farmer PB, Stockis JP, Janzowski C.
    Free Radic Res; 2004 Oct 17; 38(10):1093-100. PubMed ID: 15512797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.